CD36 is an important regulator of lipid metabolism in vivo due to its role in the facilitated uptake of long-chain FAs (fatty acids). CD36-deficient mice display reduced TAG (triacylglycerol) in muscle, but elevated hepatic TAG. Also, insulin sensitivity is enhanced peripherally, while it appears impaired in the liver [Goudriaan, Dahlmans, Teusink, Ouwens, Febbraio, Maassen, Romijn, Havekes, and Voshol (2003) , so we hypothesized that this shift must involve adaptive changes in the PPAR (peroxisome-proliferator-activated receptor) transcription factors which regulate FA metabolism. To test this, we examined mRNA levels for the three PPAR isoforms in tissues of WT (wild-type) and CD36-deficient mice following the administration of saline, glucose or olive oil by intragastric gavage. Compared with WT mice, CD36-null mice had 5-10-fold increased PPAR mRNA in adipose tissue in the basal state, and did not exhibit diet-induced changes. Correlations between adipose PPAR mRNA abundance and plasma lipids were observed in WT mice, but not in CD36-null mice. The opposite was true for hepatic PPAR mRNA levels, which correlated with plasma FA, TAG and/or glucose only in CD36-null mice. No significant differences were observed in PPAR mRNA levels in the intestine, where CD36 does not impact on FA uptake. The data suggest that CD36 and the PPARs are components of the FA-sensing machinery to respond to changes in FA flux in a tissue-specific manner.
Introduction

FA (fatty acid) uptake
FA uptake through the phospholipid bilayer of cell membranes occurs both by passive diffusion and by proteinfacilitated transfer. The facilitated component appears to mediate the major fraction of the uptake in adipocytes and muscle cells [1] . Several proteins have been implicated in facilitating membrane FA transfer, and these include the FA translocase/CD36, the plasma-membrane-bound FA-binding protein and the solute carrier family 27 member 1 (reviewed in [2] ).
CD36 as a facilitator of membrane FA uptake in rodents and humans CD36 is an 88 kDa, type I integral membrane glycoprotein expressed in many mammalian tissues. It is a multi-ligand member of the scavenger receptor superfamily, with important roles in cell adhesion [3] , angiogenesis [4] and lipoproKey words: adipose tissue, CD36, fatty acid, intestine, liver, peroxisome-proliferator-activated receptor (PPAR). Abbreviations used: FA, fatty acid; PPAR, peroxisome-proliferator-activated receptor; TAG, triacylglycerol; WT, wild-type. 1 To whom correspondence should be addressed (email nabumrad@wustl.edu).
tein binding/endocytosis [5] . CD36 was identified as a receptor for long-chain FAs via the irreversible binding of sulphosuccinimidyl FA esters [6] , which block FA transport in adipocytes [7] . More recently, the use of animal models with altered CD36 expression has greatly increased our understanding of the roles of CD36 in FA metabolism. CD36-deficient mice [8] and spontaneously hypertensive rats with mutations at the CD36 locus [9] show elevated plasma FA levels, altered insulin sensitivity and reduced uptake of FA into muscle and adipose tissue [1, 10, 11] . The FA uptake defect in adipose and muscle tissues results in a metabolic switch to enhanced glucose utilization that is manifested in the fasted state by the occurrence of hypoglycaemia and hypoinsulinaemia [11] . Improved glucose tolerance on a highstarch diet and partial protection from the diabetogenic effects of a high-fat diet are also observed in CD36-deficient mice [11] . Specifically, the muscle becomes insulin-sensitive, whereas the liver becomes insulin-resistant in the absence of CD36 [10] . In contrast, overexpression of CD36 in muscle tissues is associated with hyperglycaemia and hyperinsulinaemia as a result of glucose sparing via the enhancement in FA utilization [12] . An additional consequence of the impaired tissue FA uptake in CD36-deficient animals is its effect to strongly inhibit TAG (triacylglycerol) clearance. Prolonged chylomicronaemia is observed in CD36-null mice In humans with CD36 deficiency, plasma dyslipidaemia [14] , defective FA uptake in the heart [15] and cardiomyopathy [16] have been reported. Common polymorphisms in the CD36 gene have been identified and linked to high blood FA and TAG levels, and to an increased risk of cardiovascular disease in diabetics [17] . In summary, the data to date illustrate an important role of CD36 in modulating lipid metabolism and in regulating glucose utilization and insulin responsiveness.
PPARs (peroxisome-proliferator-activated receptors) regulate FA metabolism
Regulation of lipid metabolism in many tissues is mediated by PPARs, transcription factors in the nuclear hormone receptor superfamily that are activated by FA and FA derivatives [18] . The three main PPAR isoforms are PPARα, PPARδ and PPARγ , and they are expressed at different levels in various tissues (reviewed in [19] ). PPARγ has been shown to determine lipid deposition and insulin sensitivity of adipocytes, whereas PPARα and PPARδ have been implicated in the regulation of FA oxidation in liver and muscle. Many of these effects are mediated transcriptionally via the PPARdependent regulation of genes involved in lipid metabolism. Although FA activation of PPARs has been extensively characterized [19] , the possibility that autoregulation of PPAR gene expression by tissue FA utilization or availability has not been examined.
In the liver, PPARα has been shown to regulate CD36 gene expression, whereas PPARγ appears to have a similar effect in adipose tissue [20] . PPARγ agonists such as pioglitazone and rosiglitazone are a very promising treatment for Type II diabetes and metabolic syndrome (reviewed in [21] ). One important component of the insulin-sensitizing actions of these drugs is their ability to improve plasma FA clearance and reduce circulating levels of FA. CD36 appears to be a key component in the mechanism of action of these drugs in rodents, since the metabolic effects of pioglitazone and rosiglitazone are impaired in spontaneously hypertensive rats with dysfunctional CD36, and can be recovered by CD36 expression [22, 23] .
Nutrient sensing
The identification of nuclear hormone receptors and their natural dietary ligands has led to the notion that these transcription factors and their associated co-activators/corepressors represent the endpoint in nutrient sensing. The role played by CD36 in the transport of FA and in mediating the effects of PPARγ agonists raises the possibility that CD36 may represent an integral, upstream component in the lipid/ energy-sensing machinery. For example, a defect in the detection of FA levels should contribute to determining the metabolic phenotype of the most affected tissues, such as fat and muscle. This hypothesis was examined in the present study by measuring the alterations in PPAR mRNA abundance in response to oral administration of equicaloric amounts of glucose or TAG to WT (wild-type) and CD36-null mice.
Materials and methods
WT and CD36-null mice were fasted overnight and then given an oral gavage of saline, glucose (7.46 mg/g of body mass) or olive oil (3.5 µl/g of body mass) [the glucose and olive oil gavage each deliver 28.4 cal/g of body mass (1 cal ≡ 4.184 J)]. Plasma levels of FA, TAG and glucose were determined 2 h post-gavage using standard assays. Tissues were harvested, and relative mRNA abundance of the three PPAR isoforms was measured by real-time, quantitative PCR and normalized to cyclophilin, as described previously [24] . The genespecific, intron-spanning primers used in this analysis are: PPARα, 5 -CCA GTA CTT AGG AAG CTAG TCC G-3 (sense) and 5 -CGT GAA CTC CGT AGT GGT ACC C-3 (antisense); PPARδ, 5 -GCT GCT GCA GAA GAT GGC A-3 (sense) and 5 -CAC TAGC ATC ATC TAGG GCA TAG-3 (antisense); PPARγ , 5 -AAG ACC CAG CTC TAC AAC AGG C-3 (sense) and 5 -GCC AAC AGC TTC TCC TTC TCG G-3 (antisense).
Results and discussion
Plasma parameters in response to food administration FA levels were significantly higher in the CD36-null mice as compared with WT mice (Table 1) , and a similar trend was observed for TAG levels, in line with our previous reports of poor clearance of FA [3] and TAG-rich lipoproteins (V.A. Drover, M. Ajmal, F. Nassir, N.O. Davidson, A.M. Nauli, D. Sahoo, P. Tso and N.A. Abumrad, unpublished work) with CD36 deficiency. Plasma glucose levels were similar in all mice given either saline or glucose. However, glucose levels in olive oil-fed CD36 −/− mice were lower than in treatment-matched WT mice, consistent with the inability of FA to spare glucose utilization with CD36 deficiency. In addition, plasma glucose correlated inversely with plasma FA in CD36
−/− mice (P = 0.0031, r 2 = 0.4760, n = 16), whereas no correlation was observed in WT mice (P = 0.5241, r 2 = 0.0379, n = 13).
Adipose tissue PPAR expression
Low levels of each PPAR isoform were measured in adipose tissue from WT mice given saline or glucose (Figure 1) . Administration of olive oil markedly increased PPARγ (the main isoform in fat tissue) and PPARα with no significant effect on PPARδ. In contrast, mRNA abundance for the PPAR isoforms in CD36 −/− mice was 5-10-fold higher than in WT mice under all conditions, and exhibited little response to gavage composition (P < 0.0001 for each isoform). Collectively, the diet-induced changes in PPAR mRNA in WT mice correlated positively with plasma FA and/or TAG, whereas no such correlation was observed for CD36 −/− mice ( Table 2 ). These data indicated that adipose tissue of CD36-null mice is not accurately sensing plasma FA levels and, as a result, its PPAR response is similar in the fasted and fed (postgavage) states. The global increase in PPAR levels in CD36-deficient adipose tissue suggests further that CD36-facilitated FA uptake is important in regulating the tonic levels of these transcription factors. It remains to be determined whether the increased PPARγ expression in CD36-deficient tissue translates into enhanced expression of PPAR target genes, or whether this is reduced as a result of the lack of FA ligand for PPAR activation.
Liver PPAR expression
The liver has relatively low levels of CD36 gene expression and hepatic FA uptake in CD36-null mice is slightly increased compared with WT mice [3] , indicating that CD36-independent mechanisms facilitate FA uptake in this tissue. As a result, we expected the changes in hepatic PPAR mRNA abundance to differ from those observed in adipose tissue. No significant differences in PPAR mRNA levels were observed between WT and CD36 −/− mice which received saline or glucose. However, CD36
−/− mice which received the olive oil had significantly higher levels of PPARα (1.553 ± 0.216 compared with 0.477 ± 0.149, P < 0.05, 2-way ANOVA) and PPARδ (0.311 ± 0.040 compared with 0.114 ± 0.027, P < 0.05, 2-way ANOVA) in comparison with treatment-matched WT mice. This is consistent with the lack of peripheral FA utilization with CD36 deficiency, which enhances FA flux to the liver. Also in line with this, positive correlations were observed in CD36 −/− mice between PPARα/δ mRNA and plasma FA and TAG, whereas a negative correlation was noted with plasma glucose ( Table 2 ). The increased expression of PPARα/δ observed with high plasma FA may play an important role in favouring more FA utilization in the liver (open bars), glucose (filled bars) or olive oil (hatched bars). After 2 h, the abdominal fat pads were collected and flash-frozen in liquid nitrogen. Total RNA was prepared using standard methods [27] and used for real-time, reverse-transcriptase quantitative PCR, as described previously [24] . Intron-spanning primers specific for PPARα (A), PPARδ (B) or PPARγ (C) were used to quantify the mRNA abundance of each PPAR isoform.
Cyclophilin was used as an internal control to adjust for the RNA/cDNA yield between samples. *P < 0.01.
in response to the increased hepatic FA flux. Such correlations were not observed in WT mice, where efficient peripheral FA clearance prevents the accumulation of plasma FA. Table 2 Correlation of plasma macronutrient levels to PPAR mRNA abundance in adipose tissue, liver and jejunum Abundance of the indicated PPAR isoforms was determined by real-time, reverse-transcriptase quantitative PCR and normalized to cyclophilin as described previously [24] . Coefficients of correlation (r) were determined separately for WT and CD36-null mice using the Pearson Product Moment method and considered significant when P < 0.05. Correlations with P > 0.05 are shown as not significant (n.s. 
Intestinal PPAR expression
CD36 is highly expressed in the small intestine. Expression along the gastro-colic axis is highest in the jejunum, while the tips of the intestinal villi display the highest expression along the crypt-to-villus axis [25] . This pattern parallels that of other proteins implicated in FA uptake, such as intestinal and liver FA-binding proteins [25] . Our previous studies with the small intestine indicated that CD36 did not contribute to FA uptake into enterocytes. In this respect, the intestine appeared similar to the liver in having CD36-independent mechanisms for FA uptake. However, secretion of chylomicrons was significantly reduced in CD36-deficient mice, suggesting a role for CD36 in targeting FA to the TAG secretion pool in enterocytes (V.A. Drover, M. Ajmal, F. Nassir, N.O. Davidson, A.M. Nauli, D. Sahoo, P. Tso and N.A. Abumrad, unpublished work). As described above, we examined PPAR expression in the jejunum of WT and CD36-null mice. No significant difference was observed between the WT and CD36-null mice, regardless of gavage composition. However, jejunal PPARα correlated with plasma FA and TAG in both WT and CD36-null mice.
Summary
The role of tissue FA uptake and utilization in regulating expression of the PPARs has received little attention so far, despite the fact that FA and FA derivatives are ligands and activators of these transcription factors. Recently, Watt et al. [26] showed that pharmacological reduction of plasma FA levels in WT mice resulted in an elevation of PPARα and PPARδ mRNA abundance in muscle, possibly as an adaptive compensatory response. Our findings show that tissue FA utilization determines expression of the different PPAR isoforms in a tissue-specific fashion. The data further indicate that FA uptake exerts a tonic inhibition on the expression of all three PPAR isoforms in adipose tissue, which is relieved in the absence of CD36. The PPARs in adipose and likely muscle tissues, especially PPARγ , up-regulate CD36 expression to ensure supply of the FA ligands. In turn, CD36-dependent FA uptake may contribute to suppressing PPAR expression in a feedback loop aimed at preventing excessive lipid metabolism. The mechanism for such a regulatory cycle remains to be determined.
